BDBM72995 3-[6-(1,3-benzodioxol-5-ylmethylamino)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]-N-(4-methoxyphenyl)propanamide::MLS001095835::N-(4-methoxyphenyl)-3-[6-(piperonylamino)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]propionamide::SMR000631453::cid_20957410

SMILES CCCN(C(=O)[C@@H]1[C@@H]2[C@H](CN1C(=O)[C@@H](NC(=O)C(F)(F)F)C(C)(C)C)C2(C)C)[C@H](C#N)C[C@@H]1C(=O)Nc2ccccc21

InChI Key InChIKey=QOATXWCIJAPRNT-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 72995   

TargetReplicase polyprotein 1ab(2019-nCoV)
Trawsfynydd Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 72995BDBM72995((1R,2S,5S)-N-[(1S)-1-cyano-2-(2-oxoindolin-3-yl)et...)
Affinity DataIC50: 1.00E+3nMAssay Description:Keywords: Heat Shock Factor-1 (HSF-1), Stress Response, MG132, NIH3T3, Luminescence Assay Overview: Modified NIH3T3, transformed to express firefly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/22/2026
Entry Details
US Patent